Octachlorostyrene (OCS) is a highly chlorinated aromatic hydrocarbon that has been studied extensively due to its potential environmental and health effects. It is a persistent organic pollutant (POP) that can accumulate in the environment and bioaccumulate in food chains. OCS is typically produced as a byproduct of industrial processes, particularly the production of chlorinated solvents. It is also found in contaminated soil and water. OCS is known to be toxic to aquatic organisms and has been shown to cause developmental and reproductive problems in laboratory animals. Research on OCS focuses on its environmental fate and transport, its toxicity to various organisms, and its potential for bioremediation. The development of methods for the detection and removal of OCS from contaminated environments is also a major area of research.'
```
ID Source | ID |
---|---|
PubMed CID | 34466 |
CHEBI ID | 81542 |
SCHEMBL ID | 93255 |
MeSH ID | M0062434 |
Synonym |
---|
29082-74-4 |
1,2,3,4,5-pentachloro-6-(trichloroethenyl)benzene |
octachlorostyrene |
styrene, octachloro- |
hsdb 6203 |
trichlorovinylpentachlorobenzene |
benzene, pentachloro(trichloroethenyl)- |
brn 2057011 |
ccris 5684 |
1,2,3,4,5-pentachloro-6-(1,2,2-trichloroethenyl)benzene |
C18148 |
304368u4vh , |
unii-304368u4vh |
62601-62-1 |
SCHEMBL93255 |
octachlorostyrene [hsdb] |
CHEBI:81542 |
perchlorostyrene |
RUYUCCQRWINUHE-UHFFFAOYSA-N |
1,2,3,4,5-pentachloro-6-(1,2,2-trichlorovinyl)benzene # |
DTXSID2021074 |
octachlorostyrene 100 microg/ml in cyclohexane |
octachlorostyrene 10 microg/ml in cyclohexane |
octachlorostyrene, vial of 1 g, analytical standard |
1,2,3,4,5-pentachloro-6-(1,2,2-trichlorovinyl)benzene |
Q27155456 |
3-amino-3-[5-(2,5-dichlorophenyl)-furan-2-yl]-propionicacidamide |
octachlorostyrene 100 microg/ml in toluene |
benzene, 1,2,3,4,5-pentachloro-6-(1,2,2-trichloroethenyl)- |
Octachlorostyrene (OCS) is a persistent and bioaccumulative toxicant (PBT) that is a halogenated aromatic compound. It is present in fish of Northern European waters and the Great Lakes of America.
Excerpt | Reference | Relevance |
---|---|---|
"This study was designed to investigate the toxic effects produced by the long-term exposure to octachlorostyrene (OCS), a demonstrated environmental contaminant in the Great Lakes region of North America and the Norwegian Coast in Europe." | ( Long-term toxicity of octachlorostyrene in the rat. Chu, I; Leeson, S; Secours, VE; Shen, SY; Valli, VE; Villeneuve, DC, 1986) | 0.8 |
" These results indicate that OCS produced toxic effects at low levels of exposure and accumulated in the tissues of rats." | ( Octachlorostyrene: a 90-day toxicity study in the rat. Chu, I; Reed, B; Secours, VE; Valli, VE; Villeneuve, DC; Yagminas, A, 1984) | 1.71 |
"In recent years, microarray technology has enabled the investigation of possible mechanisms the expression of genes related to toxic compounds." | ( Whole genomic expression analysis of octachlorostyrene-induced chronic toxicity in Caenorhabditis elegans. Choung, SY; Kim, SJ, 2009) | 0.63 |
Class | Description |
---|---|
organochlorine compound | An organochlorine compound is a compound containing at least one carbon-chlorine bond. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 13 (41.94) | 18.7374 |
1990's | 3 (9.68) | 18.2507 |
2000's | 6 (19.35) | 29.6817 |
2010's | 7 (22.58) | 24.3611 |
2020's | 2 (6.45) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (20.43) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 33 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |